Velsipity 2 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FWJYE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,788
Award facts
- Contract value 100% obligated
- $17,788.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Velsipity 2 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $17,788.20, represents a non-competitive procurement and is scheduled for completion by August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Velsipity is a selective sphingosine-1-phosphate receptor modulator used in the treatment of multiple sclerosis, reflecting the pharmaceutical supplier's ongoing role in providing specialty medications for military and federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle extending through December 2026. As a child contract under this prime IDC, the delivery order exemplifies AmerisourceBergen's critical role as a major pharmaceutical distributor for federal medical procurement, supplying a diverse portfolio of brand-name and generic medications, specialty therapeutics, and medical supplies to support Defense Health Agency operations and other federal healthcare beneficiaries worldwide. The company's demonstrated capability to fulfill such requirements through competitive contracting reinforces its position as a key vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FWJYE?
SPE2DB25FWJYE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FWJYE worth?
The government has obligated $17,788 on SPE2DB25FWJYE.
Is contract SPE2DB25FWJYE an order under another contract?
Yes. SPE2DB25FWJYE is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWJYE competed?
The extent of competition for SPE2DB25FWJYE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award